In-Hospital Mortality Among Hematological Malignancy Patients Undergoing Bronchoscopy for Suspected Invasive Pulmonary Aspergillosis

Strategic Insights -

A recent study published in Mycopathologia has shed light on the high mortality rates associated with invasive pulmonary aspergillosis in hematological malignancy patients undergoing bronchoscopy. The research, conducted by a team of scientists at Uludag University in Bursa, Turkey, aimed to evaluate the risk factors associated with in-hospital mortality in this vulnerable population. The findings suggest that co-infections, particularly fungal and bacterial infections, play a significant role in determining mortality rates. Furthermore, the study highlights the importance of radiological assessment in predicting mortality, with the number of nodules in HRCT scans serving as a potential indicator of in-hospital mortality.

Key Takeaways:

  • The study included 305 patients diagnosed with possible, probable, or proven invasive pulmonary aspergillosis, of which 57 presented with fungal and bacterial co-infection.
  • In-hospital mortality was observed in 98 (33.6%) patients, with patients who were older and not in remission for hematological malignancy being at higher risk.
  • Serum GM, bronchoalveolar lavage (BAL), and bronchial lavage (BL) GM levels showed a significant relation with in-hospital mortality, but weak accuracy.
  • Multivariate analysis revealed age, remission status, number of nodules in HRCT, and having fungal infections with or without combined bacterial infection as independent risk factors for in-hospital mortality.
  • Co-infections in susceptible populations should not be overlooked, even in the presence of fungal infection evidence.
  • BAL and BL GM tended to have a stronger relation with survival than serum GM measurements taken at the same time.

Statistics:

  • 305 patients were included in the study.
  • 57 patients presented with fungal and bacterial co-infection.
  • In-hospital mortality was observed in 98 (33.6%) patients.
  • Patients who were older and not in remission for hematological malignancy were at higher risk of in-hospital mortality.
  • Serum GM, BAL, and BL GM levels showed a significant relation with in-hospital mortality, but weak accuracy.

Sources:

  • NewsRx. Findings on Invasive Pulmonary Aspergillosis Detailed by Researchers at Uludag University (In-Hospital Mortality Among Hematological Malignancy Patients Undergoing Bronchoscopy for Suspected Invasive Pulmonary Aspergillosis: Focusing on ...). TB & Outbreaks Week. October 14, 2025; p 710.
  • In-Hospital Mortality Among Hematological Malignancy Patients Undergoing Bronchoscopy for Suspected Invasive Pulmonary Aspergillosis: Focusing on Coinfections and Nodules on Chest CT. Mycopathologia, 2025;190(6):93.